Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03329378
Title Neoadjuvant Dose-Dense For Early Her2Neu Positive Breast Cancer
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Icahn School of Medicine at Mount Sinai
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mount Sinai Beth Israel New York New York 10011 United States Details
Mount Sinai West New York New York 10019 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10029 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field